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he occurrence of the novel coronavirus (COVID-19) pandemic presents an unparalleled health 
enlightenment challenge. It’s extremely contagious and erratically lethal, and the pervasiveness of 
asymptomatic prevalence makes it difficult to contain. All infectious disease epidemics rear ethical 
concerns, from the restraint of individual independence to triaging and resource provision. It seems that 
we did not take lessons from the preceding epidemics and were poorly prepared to pledge with the threat that 
COVID-19 epidemic has put forward. The COVID-19 epidemic highlighted the significance of this query to both 
pandemic preparation strategies and healthcare policies. As the outbreak turned out to be a global pandemic, 
there is an improved emphasis on finding answers for vaccine preparation, focusing on neglected diseases, 
more virome study, and research collaboration across the globe in the future, being key tools to resist infection 
spread in future. Decelerating the COVID-19 spread necessitates people to enthusiastically transform their lives 
and monitor the finest practices for social isolation and sanitation. This review provides an overview of future 
research perceptions and offers suggestions on how we can help people to believe in normal life and how this 
pandemic will strengthen the trade, affect the individual habits and values, revolution in primary health care after 
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Introduction  
Among crucial pathogens, Coronavirus that 
predominantly affect the human respiratory framework. 
Preceding eruptions of coronaviruses embrace the 
Middle East respiratory syndrome (MERS) and severe 
acute respiratory syndrome (SARS) that have been 
formerly considered as proxies that are an inordinate 
public wellbeing menace [1]. A group of infected people 
was entered into medical clinics with an underlying 
analysis of an obscure etiology pneumonia in December 
2019 [2]. Epidemiologically all of these infected people 
were connected to wet animals and the fish food market 
in Wuhan, China [3]. Primary information anticipated the 
commencement of an impending Coronavirus epidemic 
assumed the assessment of a propagation quantity for 
the Novel Coronavirus-2019 (COVID-19), entitled as 
such by WHO on 11 February 2020 which was thought 
to be ominously greater than one (ranging from 2.24-
3.58) [4]. 
From Jan 23, 2020, Wuhan and many other areas of 
China have implemented stringent quarantine 
procedures to avert and control the disease outbreak 
because of possible severe health consequences 
caused by COVID-19. Within a few months, this virus 
spread globally after China like Italy, France, and many 
other European countries. Though, it will require months 
and even years to finally solve this puzzle with its 
pathogenic characteristics like symptoms, origin, and 
immune responses to fight against the infection [5].  
In the COVID-19 epidemic restraint measures have 
concentrated on detecting, isolating, and treating 
infected people, locating and quarantining nearby links, 
and indorsing protective performances amongst the 
overall community. Therefore, to control the pandemic, 
behavioral and psychosomatic reactions of the common 
inhabitants play a significant role [6].  
The objective of this review is to deliver an optimistic 
outline for the development of future awareness plans, 
as well as offer a critical valuation and noteworthy things 
for preventing their transmission, employing lessons 
learned from the previous pandemic in history like 
Spanish flue. What measures shall we take after the 
COVID-19 outbreak? How our lives have been affected? 
What lessons we have learned from this outbreak? 
Though the outbreak is continuing, primary lessons from 
its feast can assist to appraise medical experts and 
public health executives in exertions to fight against its 
spread.     
Methods 
Literature search strategy and selection criteria 
The leading journal publishers like Elsevier, PubMed, 
and Wiley online libraries, were searched by using 
keywords like COVID-19, pandemic, neglected 
diseases, and articles with 75% similarity to the 
keywords were selected to write this article. 
Discussion 
How pandemics have changed the world as we know 
it today? 
The worldwide spread of disease is pandemic. There are 
many examples from history, out of which the most 
recent pandemic is COVID-19 as announced on March 
11th, 2020 by the World Health Organization (WHO) [7].  
The outbreak of COVID-19 reported in Wuhan, China, 
spread rapidly around the globe within a few months 
becoming a pandemic. Yet epidemics do not turn into 
pandemics as fast as the current one [8], for instance, 
the HIV disease was prevalent for years in West Africa 
before spreading like a pandemic. Today, due to 
advances in medical medicine, HIV is considered 
chronic, meaning that the disease incidence in some 
populations is steady and predictable, according to the 
American Medical Association [9]. 
The Spanish flu of 1918 was the most deadly 
pandemic in history. The virus affected an estimated 
one's population and was responsible for causing 20 to 
50 million deaths — an approximate mortality rate of 1 to 
3 percent. The virus did not originate in Spain, but it was 
the country that first reported on the epidemic, so people 
started calling it Spanish flu [10].  
Laura Spinney, a science writer, and the author 
address the epidemic of Spanish flu. She suggests that 
there are lessons to be learned from the pandemic. The 
2020 climate is drastically different from 1918, the year 
that Spanish flu began spreading across the climate. But, 
as a science writer and journalist Laura Spinney says, 
many of the public health initiatives have been close to 
the policies being taken by governments today. 
Community reunions have been banned. People had 
been told to isolate themselves and quarantine. That's 
lasted for months in some cases. It did work. Events 
didn't go smoothly — distant from it, because some 
towns suffered considerably shoddier than many others, 
and the public didn't every time follow what they were 
told by experts and officials [11]. Studies indicate, 
however, that social distancing exertions slowed the 
1918 flu spread and reduced the death percentage. 
Currently, the conditions in the world are very different 
than they were 100 years ago. In 1918, people did not 
realize that the flu was a virus, nor did they have the 
resources to create and introduce new vaccines rapidly. 
But now we know precisely about the SARS-CoV-2 virus 
that caused the COVID-19 disease, and now the world is 
trying to design a vaccine against it [12].  
There is a need to take immediate steps and make 
treatment strategies before the disease is over and we 
need to do whatever we can in the interim. The lesson 
here is not to take for granted the social distancing steps. 
It will be a hard decision to make, and when the 
coronavirus is completely gone, it will be difficult to 
predict. And the improvements in public health must be 
balanced against the stress that social distancing is 
necessary for families — particularly for those who want 
to leave there for their exclusive source of earnings — 
and on the economy as well. Lessons from 1918 flu arise 
with a major, clear warning: the last century has changed 
a lot [13]. We have commercial airplanes that are much 
more available. We have in-house. We have a much 
stronger healthcare system, too. The planet is now better 
prepared to cope with any form of illness, by producing 
vaccines to all kinds of medicines to all types of 
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antibiotics. When the outbreak occurred, the First World 
War ended and communal health officials obligated little 
or no formal procedures at the time to deal with disease-
causing pandemics that helped in contributing to its 
massive effect [14].  
Research into how the pandemic occurred and 
whether it might have been avoided in the years to come 
has contributed to changes in public healthiness and 
assisted to mitigate the risk of repeated flu-like virus 
outbreaks later. The outbreak of SARS augmented 
recognition about averting viral disease transmission, 
mainly in Hong Kong, where open surfaces have been 
repeatedly sterilized from that point forward, and face 
masks have become a conjoint prospect [15].  
But Spanish flu shows us how amazing can be the 
effects of a pandemic, even in countries that have 
already been active in improving the health of the 
population. A new pathogen can cause devastating 
destruction and lead to millions of deaths. That's why the 
Spanish flu was cited as an alert and a reason to plan 
well for major pandemic outbreaks that were perceived 
to be likable by many researchers [11].  
Research on emerging infectious diseases 
Infectious diseases are a noteworthy pressure on 
community health and economies in the world's 
economic stability. We have been amongst the 
prominent reasons for demise and disability for times and 
rose rising tests to health protection and humanoid 
development. The danger of transmissible infections is 
further compounded by the continuing proliferation of 
novel, unidentified, and ancient infectious diseases [16].   
In the previous three and a half decades, a maximum 
of thirty novel human-affected infectious mediators have 
appeared, a maximum of them are zoonotic, and their 
pedigrees have depicted to be strongly associated with 
socio-economic, political, and environmental influences. 
While these aspects tend to upsurge, there is concern 
that infectious disease puts individuals in augmented 
interaction with the infection that causes pathogens [17]. 
Developing and abandoned infectious diseases pose 
a significant danger to community health, and outbreaks 
of transmissible diseases may have severe political, 
economic, and social consequences. Ample has been 
erudite from preceding epidemic incidents, and 
extensive progress has been completed subsequently 
the seminal IOM report, which highlighted the critical 
perception of developing the infectious disease [18]. 
Government funding is required because pandemic 
drugs are extremely high- investments; public funding 
would reduce the risk to pharmaceutical companies and 
allow them to jump in with both feet. Additionally, 
governments and other donors will need to finance 
production facilities — as a global public good — which 
can produce a supply of vaccines within weeks. These 
facilities will produce vaccines in normal times for regular 
immunization programs and quickly be refitted for 
development during a pandemic. Lastly, governments 
would need to fund vaccine production and delivery to 
the communities that need it. Billions of dollars are a lot 
of money for anti-pandemic activities. But that is the 
investment size required to solve the problem [19].  
Neglected tropical diseases – hanging swords 
As COVID-19 is growing globally, leaving uncertainty 
and confusion behind in its wake, global efforts are 
underway to find a cure [20]. Yet, many other infectious 
diseases that kill millions each year lack the same 
degree of response. These forms of neglected tropical 
diseases are a large category of transmissible infections 
that affect over two billion people and cost billions of 
developed economies  [21].  
More than a thousand million people are diagnosed 
with some or more of the neglected tropical diseases 
(NTDs), one-sixth of the world's population, mainly in 
developing countries. In Nigeria and other western 
African countries such as Liberia, Benin, Mali, Ghana, 
Sierra Leone, and Guinea Lassa fever is an example and 
endemic. It is reportedly killing about 17.8 percent of 
those infected in Nigeria. Reported first in 1969, there is 
still no effective vaccine for preventing it [22].  
An acute viral hemorrhagic disease similar to Ebola, 
the infection may last anywhere from two days to twenty-
one days and is transmissible to humans through food or 
household products contact infected with rodent feces or 
urine or from human to human. It means that successful 
vaccines will remain a pipe dream and that effective 
experiments and therapies where they exist would not be 
made widely available and wiped out these diseases in 
adequate quantities. Those are the steps to be taken to 
address those neglected diseases in light of this fact [23]. 
Emphasis on metagenomics and modeling for 
viruses’ evolution 
Metagenomics (VM) identification and characterization 
of viruses is a fairly new technique that takes advantage 
of next-generation sequencing (NGS) sensitivity while 
being largely unspecific to any particular virus present in 
a given sample. Virus species (viromes) are structurally 
and functionally complex and are distinct from 
ecosystems in hosts and environments [24]. 
New and better ways of medical responses 
A significant challenge in reacting to COVID-19 is the 
safety of health care personnel and the prevention of 
nosocomial infections, which have become major 
problems in China. It will involve a mix of administrative 
approaches to hospitals, technical monitoring, and 
special training of medical staff and the usage of 
personal protective equipment [25]. 
Since a proportion of patients may have a serious 
illness and need critical care services, ICUs need 
extensive planning. This preparation involves evaluation 
of ICU bed capacity, the potential to increase ICU bed 
space with alternative care sites such as step-down units 
and post-anesthesia treatment facilities, mechanical 
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Diagnostic testing needs to be expanded 
Until recently the CDC carried out all diagnostic testing 
and was focused on the existence of both travel history 
to China plus clinical symptoms. The authority was given 
this week to state and public health laboratories as well 
as other laboratories to develop and use their diagnostic 
SARS-CoV-2 tests. This will allow wider testing and 
results in additional cases being recognized. The CDC 
and public health laboratories are not equipped to 
research on the scale required to make the diagnosis in 
an epidemic for clinics and hospitals. To achieve a high-
level test capability, the major clinical testing companies 
would need to develop and manufacture large-scale test 
kits [26]. 
Serological assays are also required particularly for 
monitoring purposes and to help determine the precise 
rate of case-fatality. Clinicians and specialists in public 
health would need to be given specific details about the 
operational characteristics of SARS-CoV-2 diagnostic 
testing. They need to know these tests 'false-positive, 
false-negative, and predictive principles to make the best 
clinical and public health [27].  
Anesthesia providers are at an elevated risk of 
contamination; thus, it is not possible to overemphasize 
the importance of infection prevention to these providers. 
Personal protective measures must be taken in caring for 
patients with confirmed or suspected infections. The goal 
is to avoid cross-infection in this epidemic and if we do 
not prove it, we cannot protect our patients  [28].  
Rapid development and intervention of vaccine 
The COVID-19 vaccines need is worldwide though the 
requirement is divided differently among communities. 
For healthcare staff and individuals at the greater threat 
of severe infection and death, vaccines should possibly 
be prioritized. Countries with high incomes do not 
monopolize the COVID-19 vaccines supply globally. But 
this risk is genuine: wealthy countries negotiated in the 
period of influenza A / H1N1 pandemic in 2009 [29].  
Three imperatives should direct this vaccine effort: 
speed, global access, and manufacturing and delivery at 
scale. The Coalition for Advances in Epidemic 
Preparedness (CEPI) and World Bank, that finances the 
production of epidemic vaccines, jointly organized an 
international discussion on these priorities in February 
2020 [30]. This consultation led to the creation of a task 
force for the production of vaccines COVID-19 which is 
now focusing on how to fund and produce global access 
vaccines. CEPI reports that the production of up to three 
vaccines would necessitate an income of a minimum of 
US$ 2 billion over the next 12–18 months [31]. 
This prediction comprises phase 1 experimental trials 
of 8 aspirants for the vaccine, advancement of up to 6 
aspirants during phase two and three trials, fulfillment of 
monitoring and safety criteria for at least 3 vaccines, and 
enhancement of the universal development aptitude for 
3 vaccines. However, this calculation does not contain 
manufacturing or production costs [32].  
Research collaborations across the globe 
Notably, associated organizations and nations 
collaborating in COVID-19 research will inform the 
effectiveness of global research collaboration, especially 
in complex public health problems where multiple actors 
from various institutions and contexts can provide 
diverse resources and skills to resolve information gaps 
more effectively than individualistic approaches [33].  
The gene sequences of the virus were made available 
via a public access genetics bank in early January. 
Laboratories around the world have since been 
struggling to understand the virus – its signs, similarities 
with existing coronaviruses, how it spreads, and how 
quickly. Such front-seat policies have dominated 
academic institutions in China, the US, Japan, and 
Europe [34]. 
To date, six teams have publicly shared their 
guidelines for molecular research with the WHO. Those 
include scholars from the University of Hong Kong and 
the University of Medicine of the Charité Berlin in 
Germany. For example, one of the first studies for the 
2019 coronavirus was produced by the Berlin research 
team as soon as news of the outbreak emerged due to 
their experience in SARS-related viruses [35].  
To enhance regional and global awareness on chronic 
and emerging diseases affecting global populations, 
future efforts are also expected to concentrate on 
improving research capacity in these contexts. It is also 
necessary to acknowledge the need for global 
cooperation since the magnitude of the problem 
demands a series of large-scale analyzes, exchange of 
perspectives, information [36]. 
More specifically, increased research collaborations 
are likely to promote confidence and cooperation in the 
global creation of scalable solutions, minimizing costs, 
and optimizing human benefits across borders.24,25 
Learning from research collaboration will foster optimism 
in addressing current global health inequalities, 
particularly in developing vaccines and other preventive 
solutions. Such aspects are important for the overall 
development of research and practice relevant to 
COVID-19 as the existing collaborative evidence 
indicates the fragmented growth of research groups, 
which could impact the true potential that collaborative 
efforts can bring in this scenario [37]. 
Helping people believe in normal life after the end 
of the pandemic 
While the coronavirus pandemic persists, so many 
people overthink things they never thought about at all. 
Should you hang out? And if you have another person 
walking downwind? Even if you're standing at a 
crosswalk and there's someone around? And if you go 
for a run and another runner heads for you, and the 
sidewalk is narrow? Daily worldliness seems to warrant 
a strategy. Scientists in some fields of genetics, logistics, 
medical science, economy, and many others will support 
those people who are straightaway affected by the 
pandemic by developing diagnostic devices, drugs, and 
vaccinations; evaluating counter-recession measures; 
through food and medicine shipping efficiency [38].
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The pandemic of Covid-19 carried massive public 
trials to our streets, homes, towns, nations, and globally. 
The implications of this public trial will affect humanity as 
a whole, perhaps quite unequally, as well as in the future. 
While we write these sentences, physicians and nurses 
are taking major risks in terms of wellbeing to help our 
well-being [39].  
Teachers are working continuously even at nights and 
weekends in designing educational resources and 
helping students online. Persons employed in many 
other occupations, retirees, teenagers, and others, must 
stay at home while watching the bulletin and follow 
guidelines. Both of these positions are less imperative 
compared to other professionals. Although we 
understandably want health care, food, and education, 
the virus can only be limited through self-restraint. 
In the case of habits proposed in response to COVID-
19, we must assist, for example, people who switch to an 
online system, working from home that they would find 
additional spare time due to reduced commutes. Extra 
time at home can also mean added time with family 
members, which would be great. 
Being at home, far away from gatherings may be a 
chance to develop a habit or hobby, like gardening, 
reading, or cooking. If time allows, one may want to 
discuss the possibility of benefits for people with more 
time spent at home. 
Perpetual changes in customs and morals 
Most of our lives are commonplace, and routines are 
very successful in helping us work, caring for our 
families, and achieving our goals. What a shock does to 
the body is to change those patterns. People work and 
move differently, their everyday activities, and adjusting 
the very pace of their lives, including what they eat and 
how they interact with their families. 
What we know about shocks like this and system 
change is more than because they can have enduring 
impacts on the beliefs of people. We know that 
communities that go through war are building stronger 
relations. The pandemic is far from a fight, but it calls for 
a pull together. And when people understand what 
collective action can do, it can affect how they respond 
to others, contributing to a greater sense of community 
[40]. 
Revolution in the primary healthcare provision 
We haven't seen an emergency on that magnitude in 
public health in a century. This imposes a huge 
psychological toll on the world population and calls for 
change are expected to be made. Citizens around the 
world will use COVID-19 as a clear justification for 
seeking universal healthcare. 
We may also see governments improving their 
capacity to deploy ICU-level equipment, constructing 
protective gear and ventilators stockpiles, increasing 
emergency hospital facilities, and relying more heavily 
on the military to combat disease. New technology will 
become ever more common, and the use of 
telemedicine, as well as home research, is likely to 
increase [41]. 
Effect on universal trade  
The COVID-19 pandemic showed us the immense 
economic cost of slowing down global trade, particularly 
shipping. This also reveals how dependent on the global 
supply chain we are, even for medical supplies such as 
masks and test materials [42]. Once this pandemic ends, 
I believe that global trade will resume and become much 
stronger and that any damage to the supply chain will be 
temporary. This pandemic is forcing many countries at 
the national level to rethink their social policies, 
particularly social security and healthcare. Additionally, 
an attempt is being made to support informal sector 
employees. If these policies continue after the outbreak 
or any version of them, it will help to reduce inequality. 
We also see governments helping banks and 
businesses mitigate the impacts of both the outbreak and 
the lockdowns. This is primarily to prevent the economy 
from further failure. There might be a change in policy 
towards these industries after the pandemic, but when 
they don't need them, it should be carefully balanced by 
offering incentives or tax cuts [43]. 
Future directions 
To control the recent pandemic necessitates arduous 
measures to lessen COVID-19 transmission from human 
to human. Distinct consideration and energies should be 
specified to protecting or decreasing communication 
between susceptible individuals, comprising health 
professionals, children, and the elder people. A guide for 
health care provides, medical practitioners, and persons 
in public health have been distributed  [44,45]. 
The initial COVID-19 pandemic demise events 
happened mostly in aged individuals, possibly because 
of a poor immune system that allows for quicker growth 
of viral infection. Communal efficacies and amenities will 
frequently deliver disinfecting chemicals for washing 
hands. Bodily connection with misty and infested 
exteriors in the virus treatment should be measured. 
China and many other countries like the US have 
familiarized noteworthy deterrence and controlling 
measures to screen more progression of the virus, 
comprising travel monitoring. The COVID-19 
epidemiological variations should be measured taking 
into interpretation probable transmission ways and 
subclinical infections, as well as human adaptation, 
evolution, and spread of viruses [46]. 
These provide information but are not limited to like 
how and how much were screened, what percentage of 
those returned positive, and even if this percentage rests 
persistent or mutable? Too little pediatric events have 
been stated still; is this because of deficiency of analysis 
or actual nonexistence of infection? Few basic issues will 
offer a basis for implementing more concrete and 
comprehensive public health interventions. 
CONCLUSION 
The COVID-19 caused by new SARS-CoV-2 begun in 
December 2019 in China and all over the world in less 
than two months, bringing economical, medical, 
scientific, religious, political, and psychological pressure 
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among the population. Sooner or later, the pandemic of 
novel coronavirus will end but at what time and with what 
damage, we don't have the foggiest idea. For the 
present, discontinuous flare-ups will proceed until the 
population develops vaccine or herd immunity. 
Regardless, the yearning to return to the old life will 
observe a few difficulties as some of the ways of life 
changes adjusted to straighten the Covid-19 curve will 
remain until the end of time. While, with whatever cost it 
might require, we have no other option yet to stop the 
plague at the earliest opportunity and take our life back 
to normal. 
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